00000nam 22000008a 4500 9.830850 CaOODSP 20221107145623 cr ||||||||||| 170119s2017 onc o f000 0 eng d 978-0-660-07290-6 CaOODSP eng n-cn--- HP40-157/1-2017E-PDF Updated recommendations on human papillomavirus (HPV) vaccines [electronic resource] : 9-valent HPV vaccine 2-dose immunization schedule and the use of HPV vaccines in immunocompromised populations. At head of title: Advisory Committee Statement (ACS), National Advisory Committee on Immunization (NACI) 9-valent HPV vaccine 2-dose immunization schedule [Ottawa] : Public Health Agency of Canada, 2017. 29 p. Issued also in HTML format. Issued also in French under title: Recommandations mises à jour sur les vaccins contre le virus du papillome humain (VPH) : calendrier de vaccination du vaccin nonavalent contre le VPH à deux doses et utilisation des vaccins anti-VPH chez les populations immunodéprimées. Includes bibliographical references. "Human papillomavirus (HPV) infections are the most common sexually transmitted infections. There are over 100 types of HPV, and they are broadly classified into high and low risk types"--Summary, p. 3. gccst Sexually transmitted diseases gccst Immunization Canada. National Advisory Committee on Immunization. Public Health Agency of Canada. Recommandations mises à jour sur les vaccins contre le virus du papillome humain (VPH) (CaOODSP)9.830853 PDF 332 KB https://publications.gc.ca/collections/collection_2017/aspc-phac/HP40-157-1-2017-eng.pdf HTML N/A https://www.canada.ca/en/public-health/services/publications/healthy-living/updated-recommendations-human-papillomavirus-immunization-schedule-immunocompromised-populations.html Pub.: 160301